Variant report

Variant	rs13045861
Chromosome Location	chr20:23106988-23106989
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:5)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr20:23105413..23107552-chr20:23159018..23161237,2	K562	blood:
2	chr20:23106418..23109174-chr20:23126935..23129451,2	K562	blood:
3	chr20:23103623..23110911-chr20:23111294..23114699,12	K562	blood:
4	chr20:23099426..23103463-chr20:23105068..23107847,3	K562	blood:
5	chr20:23095719..23097726-chr20:23106686..23108284,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CD93-2	chr20:23105705-23107175	ENSG00000233746
2	lnc-CD93-2	chr20:23105705-23107175	XLOC_013689

No data

Variant related genes	Relation type
ENSG00000233746	Chromatin interaction

Extended variants
information (count: 11 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:9)

rs_ID	r²[population]
rs6083009	1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6083010	0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs6083012	0.87[AMR][1000 genomes]
rs6132568	0.86[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs6137837	0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6137840	0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs844828	0.85[EUR][1000 genomes]
rs844829	0.85[EUR][1000 genomes]
rs946369	0.88[AFR][1000 genomes];0.95[AMR][1000 genomes];0.91[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:2 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv2758516	chr20:23029404-23173240	Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases
2	esv2758789	chr20:23029404-23179604	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Strong transcription Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:64 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:23085800-23114600	Enhancers	Placenta	Placenta
2	chr20:23097600-23110200	Weak transcription	Pancreas	Pancrea
3	chr20:23100200-23111200	Enhancers	Fetal Thymus	thymus
4	chr20:23101200-23109400	Weak transcription	Liver	Liver
5	chr20:23101800-23109200	Weak transcription	Right Ventricle	heart
6	chr20:23102000-23114000	Weak transcription	Rectal Mucosa Donor 31	rectum
7	chr20:23103200-23109800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr20:23104000-23108000	Enhancers	Fetal Muscle Trunk	muscle
9	chr20:23104600-23107200	Enhancers	Placenta Amnion	Placenta Amnion
10	chr20:23104600-23111600	Enhancers	Primary monocytes fromperipheralblood	blood
11	chr20:23104800-23107400	Enhancers	Brain Cingulate Gyrus	brain
12	chr20:23105000-23107200	Enhancers	Cortex derived primary cultured neurospheres	brain
13	chr20:23105000-23109800	Enhancers	Brain Hippocampus Middle	brain
14	chr20:23105200-23107200	Enhancers	Duodenum Mucosa	Duodenum
15	chr20:23105200-23109200	Weak transcription	Fetal Lung	lung
16	chr20:23105200-23111000	Enhancers	Fetal Muscle Leg	muscle
17	chr20:23105400-23107000	Enhancers	Brain Substantia Nigra	brain
18	chr20:23105400-23107600	Enhancers	K562	blood
19	chr20:23105400-23107800	Flanking Active TSS	Dnd41	blood
20	chr20:23105600-23108600	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
21	chr20:23105800-23107000	Enhancers	HSMM	muscle
22	chr20:23105800-23107000	Enhancers	NHDF-Ad	bronchial
23	chr20:23105800-23107400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr20:23105800-23107400	Enhancers	Fetal Heart	heart
25	chr20:23105800-23107600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr20:23105800-23107600	Enhancers	Brain Inferior Temporal Lobe	brain
27	chr20:23105800-23107600	Enhancers	GM12878-XiMat	blood
28	chr20:23105800-23107600	Enhancers	NHLF	lung
29	chr20:23105800-23108200	Enhancers	Psoas Muscle	Psoas
30	chr20:23105800-23108400	Enhancers	Lung	lung
31	chr20:23105800-23108600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr20:23105800-23110000	Enhancers	Primary B cells from cord blood	blood
33	chr20:23105800-23110000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
34	chr20:23105800-23111000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
35	chr20:23106000-23107000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
36	chr20:23106000-23107000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
37	chr20:23106000-23107200	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr20:23106000-23107200	Enhancers	HSMMtube	muscle
39	chr20:23106000-23107400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
40	chr20:23106000-23107600	Enhancers	Left Ventricle	heart
41	chr20:23106000-23108000	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
42	chr20:23106000-23108000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr20:23106000-23112000	Enhancers	Adipose Nuclei	Adipose
44	chr20:23106200-23107000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
45	chr20:23106200-23110200	Weak transcription	Fetal Intestine Small	intestine
46	chr20:23106400-23107800	Enhancers	Primary B cells from peripheral blood	blood
47	chr20:23106400-23108200	Enhancers	Primary hematopoietic stem cells	blood
48	chr20:23106400-23108400	Enhancers	Fetal Stomach	stomach
49	chr20:23106400-23108600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
50	chr20:23106400-23109600	Enhancers	Primary T cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links